Stimulatory effects of vasopressin on progesterone production and BMP signaling by ovarian granulosa cells

Biochem Biophys Res Commun. 2023 Jul 30:667:132-137. doi: 10.1016/j.bbrc.2023.05.058. Epub 2023 May 18.

Abstract

The aim of the present study was to clarify the effects of arginine vasopressin (AVP) on ovarian steroid production and its functional relationship to the ovarian bone morphogenetic protein (BMP) system. The results showed that AVP treatment significantly increased gonadotropin- and forskolin-induced progesterone synthesis by primary culture of rat granulosa cells and human granulosa cells, respectively. In contrast, estradiol production was not significantly affected by AVP. Treatment with AVP significantly increased forskolin-induced cAMP synthesis by human granulosa cells and mRNA levels of the progesterogenic enzymes CYP11A1 and HSD3B2 in the cells. On the other hand, AVP also enhanced BMP-15-induced phosphorylation of SMAD1/5/9 and ID1 transcription. It was further revealed that the expression levels of BMP receptors, including ALK3, ALK6 and BMPR2, were upregulated by AVP. Collectively, the results indicate that AVP stimulates progesterone production via the cAMP-PKA pathway with upregulation of BMP signaling that inhibits progesterone production, which may lead to fine adjustment of progesterone biosynthesis by granulosa cells.

Keywords: Bone morphogenetic protein-15; Granulosa cell; Ovary; Steroidogenesis; Vasopressin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Morphogenetic Proteins / metabolism
  • Cells, Cultured
  • Colforsin / pharmacology
  • Female
  • Follicle Stimulating Hormone* / metabolism
  • Granulosa Cells / metabolism
  • Humans
  • Progesterone* / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Vasopressins / metabolism
  • Vasopressins / pharmacology

Substances

  • AVP protein, human
  • Bone Morphogenetic Proteins
  • Colforsin
  • Follicle Stimulating Hormone
  • Progesterone
  • Vasopressins
  • Avp protein, rat